TAPI-1
Selleck Chemicals
SKU:S7434-1MG
Couldn't load pickup availability
TAPI-1 is an inhibitor of MMP used in studies of Apoptosis. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and inflammation models.
By inhibiting MMP, TAPI-1 can be used to examine caspase-associated cell-death signaling and survival decisions. The protease annotation adds relevance to protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving MMP
- Pathway perturbation studies connected to Apoptosis
- Concentration-response inhibition and target-dependence studies
- Protease-activity, cleavage, and substrate-processing assays
Overall, TAPI-1 is appropriate when a defined chemical perturbant is needed to connect MMP with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- MMP
- Target Class:
- Protease
- Pathways:
- Apoptosis
- Research Area:
- Apoptosis • Cancer • Inflammation
- CAS No.:
- 171235-71-5
- Molecular Weight:
- 499.60
- Formula:
- C₂₆H₃₇N₅O₅
- SMILES:
- CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CC2=CC=CC=C2C=C1)C(=O)NC(C)C(=O)NCCN
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.